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INTRODUCTION
Group A Streptococcus (GAS; Streptococcus pyogenes) is a Grampositive bacterium that causes a number of clinical conditions, ranging from superficial, self-limiting manifestations such as pharyngitis and impetigo to invasive tissue infections such as necrotising fasciitis and streptococcal toxic shock syndrome. GAS infection can also lead to non-suppurative autoimmune sequelae including acute rheumatic fever (ARF) that can lead to rheumatic heart disease (RHD). RHD is responsible for more than half of the ∼500 000 deaths caused annually by the bacterium (Carapetis et al. 2005) . The majority of disease burden is found in developing nations, although there is also a very high incidence of disease in the indigenous populations of New Zealand and Australia, often appearing to follow impetigo rather than pharyngitis as is observed in other settings (McDonald et al. 2006; Williamson et al. 2016) . The high incidence of ARF in indigenous populations where there is otherwise a low prevalence of GAS disease has been described as a marker of health inequality (Carapetis 2007 ). An urgent need for a GAS vaccine has recently been highlighted by the World Health Organization .
GAS is an exclusively human pathogen and predominantly exists extracellularly. The bacterium encodes a wide array of secreted and surface expressed virulence factors that allow for infection of different tissue niches. Virulence factors of GAS include multiple adhesins capable of binding to numerous host proteins, enabling the bacterium to establish infections on skin and/or pharyngeal epithelia, and multiple proteases and nucleases, allowing for the dissemination of GAS to other sites or systemically (Cunningham 2000; Davies et al. 2014; Walker et al. 2014; Brouwer et al. 2016) . Moreover, the ability of GAS to evade the host immune system is multifaceted, involving masking of antigenic epitopes (Moses et al. 1997) , recruitment of host negative regulators of the immune response (Horstmann et al. 1988; Ermert et al. 2015; Agrahari et al. 2016) and targeted degradation of immune molecules (Terao et al. 2008; Ly et al. 2014) . There is also evidence that invasion into host cells by GAS is utilised for the purpose of immune evasion (Rohde and Cleary 2016) .
One of the most important GAS virulence factors, the M protein, has numerous functions in adhesion and immune evasion and has been extensively studied. Interestingly, a number of other GAS proteins with predicted structural and functional similarity to M proteins, termed M-like proteins, have been described but not so well researched. Here, we analyse historical and more recent studies of the M-like proteins, and highlight the importance of examining these proteins in the context of GAS virulence, with a particular focus on their contribution to host site specificity, role during infection and vaccine potential.
THE M PROTEIN: THE 'PROTOTYPE' FOR THE M AND M-LIKE PROTEIN FAMILY
The M protein, the most well-characterised GAS virulence determinant, is a surface expressed coiled coil protein that extends up to 60 nm from the cell wall (Phillips et al. 1981; McNamara et al. 2008) and interacts with numerous proteins in the host extracellular matrix and serum. The contribution to virulence of the M protein is predominantly attributed to immune modulatory effects, mediated by the binding of host proteins such as immunoglobulins (Ig) and fibrinogen (Smeesters, McMillan and Sriprakash 2010) . The M protein has been shown to be immunogenic; however, vaccine development targeting this protein has been hindered by the large diversity in the most immunogenic region of the protein at the N-terminal. Despite this, one leading GAS vaccine candidate is based on multiple N-terminal M protein antigens (Dale et al. 2011 (Dale et al. , 2013 Steer et al. 2016) . M proteins are encoded by emm genes, and the sequencing of the 5 end of the emm gene (encoding the hypervariable N-terminus of M protein) is the basis for emm-typing that has identified more than 200 antigenic variants (McMillan et al. 2013) . A more recent typing system based on the full sequence of the emm gene has been developed that classifies different M proteins into two main clades (X and Y), constituting a reduced number (48) of functionally relevant clusters (Smeesters et al. 2008; Smeesters, Dramaix and Melderen 2010; Sanderson-Smith et al. 2014; Shulman et al. 2014) . The multiple roles of the M protein in GAS virulence have been extensively reviewed (Cunningham 2000; Smeesters, McMillan and Sriprakash 2010; Walker et al. 2014) .
M proteins are attached to the bacterial cell wall at their Cterminus with the more variable N-terminus extending into the extracellular medium and interacting with host proteins. The proteins have been shown to contain an α-helical coiled-coil secondary structure (Phillips et al. 1981; McNamara et al. 2008) and to comprise several structural domains: a proline-glycinethreonine-serine (PGTS)-rich region, a cell-wall-associated region, a number of repeats and a variable length N-terminal non-helical region (Fig. 1) . M proteins are produced as proproteins and contain an N-terminal signal sequence targeting them to the secretory apparatus and a C-terminal cell wall sorting signal (CWS). The cleavable signal sequence contains the YSLRKX 3 GX 2 S motif conserved across various serotypes (Podbielski, Weber-Heynemann and Cleary 1994) . The CWS is composed of an LPXTG motif, a hydrophobic stretch and a few positive amino acids (polar tail) (Fischetti, Pancholi and Schneewind 1990; Schneewind, Model and Fischetti 1992) . The LPXTG motif, once exposed outside the membrane, is cleaved by a sortase A and attached to lipid II, leading to the attachment of the mature protein to the cell wall (Mazmanian et al. 1999; Barnett and Scott 2002; Perry et al. 2002; Ruzin et al. 2002; Marraffini, Dedent and Schneewind 2006) .
HISTORY OF DISCOVERY AND NOMENCLATURE OF M-LIKE PROTEINS
It was first recognised in 1961 that GAS were capable of expressing more than one form of M protein (Wiley and Wilson 1961) (Fig. 2) . This finding was based on early studies of multiple isolates of an M14 serotype strain that produced two proteins with characteristics typically attributed to M proteins, such as cell wall localisation, susceptibility to trypsin digestion and the induction of bactericidal antibodies (Wiley and Wilson 1961) . At that time, molecular roles of the M protein were largely unknown, but were primarily defined by their contribution to the evasion of phagocytosis (Lancefield 1962) . By 1979, it had been shown that many strains of GAS possessed the ability to bind immunoglobulins of different isotypes, via proteins distinct from M proteins, called Fc receptors (FcR; FcRA of GAS) (Christensen et al. 1979) . The following year it was shown that an M4 isolate possessed separate IgA and IgG FcRAs (Schalén et al. 1980) and , that antibodies against FcRA from an M15 isolate could opsonise GAS (Svensson, Christensen and Schalen 1986) . At the same time, Yarnall and Boyle (1986) found two antigenically similar IgG-binding FcRAs expressed by a single GAS isolate, one able to bind IgG1, IgG2 and IgG4 and the other binding IgG3. In 1987, Heath and Cleary discovered the fcrA76 gene located upstream of the emm76 gene, harbouring considerable similarities with a number of published emm genes (encoding M1, M6, M12 and M24). This led the authors to postulate the existence of a 'superfamily' of surface proteins with heterologous functions Cleary 1987, 1989) . Meanwhile, two proteins with closely linked genes were found in an M4 isolate, the IgA-binding Arp4 later identified as an M4 protein and a fibrinogen-binding protein that was described as an 'M protein-like receptor' (Lindahl 1989) .
The first instance of the designation enn for the gene downstream of the emm gene was in an M49 isolate. Both the enn and emm genes had similar sequence structure, and the protein product of the gene ennX was found to not bind IgG, distinguishing it from FcRAs characterised previously (Haanes and Figure 1 . Schematic of the predicted structure of the M-like proteins, Mrp and Enn, based on known and predicted structural features of the M protein. The signal peptide is 41aa and is cleaved during formation of the mature protein on the cell surface. Following this is the N-terminal, the most variable portion of all three protein families although considerably less variable in M-like proteins than M proteins. The central core is an EQ-rich portion in Mrp and M proteins, and an 18 aa motif in Enn proteins. The exposed C-terminal portion of Enn proteins contain C-repeats like those of Emm proteins, whereas Mrp proteins contain A repeats that differ in both sequence and predicted structure to C repeats. The cell-wall-associated portion (in blue in Fig. 1 ) is half the length in Mrp than Enn proteins. A 17-amino-acid consensus sequence (not pictured) on the C-terminal side of the cell-wall-associated region is followed by a PGTS-rich domain found in all three protein families and is highly conserved within each family. The PGTS domain contains the LPXTG motif that is cleaved to form the mature protein, leaving a helical portion (HP) embedded in the cell membrane and a polar tail (PT) in the cell cytoplasm. . The term 'M-like' protein was first used by Bessen and Fischetti (1992) , when they described two proteins derived from an M2 isolate, the IgA-binding protein encoded by the emmL2.2 gene, immediately downstream of emmL2.1. The emmL2.2 gene was similar in sequence to the ennX gene and the emmL2.1 gene to previously characterised emm genes (Bessen and Fischetti 1992) . Stenberg, O'Toole and Lindahl (1992) coined the term Mrp (for M-related protein) for an IgG1, IgG2, IgG4 and fibrinogen-binding protein that was found in four strains, two with Arp proteins and two with streptococcal immunoglobulin receptor proteins that are now considered M proteins. The Mrp4 gene sequence, upstream of arp4, was found to share sequence similarities with FcRA76 (O'Toole et al. 1992 ) and the gene for enn4 was mapped to downstream of arp4 (Jeppson, Frithz and Hedén 1992) . There remains a need for an up-to-date definition of M and M-like proteins based on functional and genomic characterisations.
Mga regulon
The emm-like genes are found within the chromosomal locus now designated as the mga (multiple gene activator) regulon but previously called the VirR (virulence regulator) and Mry (M protein RNA yield) locus (Spanier, Jones and Cleary 1984; Caparon and Scott 1987) . This regulon spans from the start of the mga gene to the end of the scpA gene and houses a varied number of emm and emm-like genes, depending on the strain in question. The mga gene encodes a positive regulator of transcription, Mga, which controls expression of proteins within the mga regulon as well as numerous other important virulence factors and metabolic systems. Mga activity is highest during the exponential phase of GAS growth, in response to favourable conditions such as high CO 2 , iron and sugar levels. Products of genes directly regulated by Mga are involved in the early stages of GAS infection, such as adherence and immune evasion. The scpA gene product, C5a peptidase, is a cell-wall-anchored proteolytic enzyme and is involved in the inhibition of complement-mediated immunity (Cleary et al. 1992) . The sof gene encoding serum opacity factor (SOF) is downstream and relatively distal to the mga regulon, though it is also regulated by Mga (Almengor, Walters and McIver 2006) . The Mga regulator has been shown to affect expression of over 10% of the GAS genome (Hondorp and McIver 2007) .
As described above, the classification of M-like proteins is complicated by discordant designations, in part due to simultaneous characterisations and incomplete functional data (Fig. 2) . In 1993, the differentiation between the members of the M-like proteins family was determined genetically based on oligonucleotide hybridisation studies. By analysis of the mga regulon in 32 different GAS serotypes, Hollingshead et al. (1993) proposed five genetic patterns (A to E) depending on the presence and order of emm, enn and mrp genes (Fig. 3) . A simple distinction between the emm-like family of genes becomes evident upon examination of their genetic loci; with few exceptions, the order of genes is invariably mrp, emm and enn (Podbielski 1993) .
In strains in which the sof gene is present (i.e. SOF + strains), the mga regulon typically contains three emm-like genes, namely mrp, emm and enn, and exclusively in this stated order (Hollingshead et al. 1993) . These SOF + strains represent the Epattern strains and are found in clade X clusters (SandersonSmith et al. 2014) . These strains are considered 'generalist' as they are often associated with skin, throat and other clinical manifestations of GAS disease (Bessen et al. 1996) . The emm-like gene family has a more variable composition in SOF − strains.
D pattern strains, which typically cause skin infections, also harbour mrp, emm and enn genes (Bessen et al. 1996; Parks, Smeesters and Steer 2012) . Strains from M pattern, A, B and C, have the same patterns of clinical manifestations with historical links to pharyngitis and ARF. They all lack the mrp gene, have a single emm gene, or two emm genes, or an emm gene and an enn gene, respectively (Bessen et al. 1996) . The mga gene in strains of patterns C, D and E is thought to differ to that of A and B patterns by up to 24.5% at the 3 end of the gene, whereas mga sequences within strains containing only a single emm gene contain only 3% sequence variation (Haanes and Cleary 1989; Hollingshead et al. 1993; Podbielski, Flosdorff and Weber-Heynemann 1995) (Fig. 3) .
SEQUENCES, DOMAINS AND BINDING PARTNERS OF M-LIKE PROTEINS

Mrp protein
There is considerable homology in sequence and sequence structure between mrp and emm genes. The first mrp gene identified (fcrA76; mrp76) has an open reading frame (ORF) of 1215 nucleotides, encoding a predicted protein of 405 amino acids (including the signal peptide sequence). The 81 most C-terminal amino acids of Mrp76 exhibit 70% sequence identity to the M1, M6, M12 and M24 amino acid sequences. The degree and location of sequence conservation led the authors to postulate that emm and mrp have evolved from a common ancestral gene Cleary 1987, 1989) . Based on detection of mRNA, expression of mrp in an M49 isolate (CS101) may be four times lower than the emm49 gene. Although data concerning the structure of M-like proteins are relatively scarce compared with that of M proteins, they are thought to have several structural domains in common: namely a PGTS-rich region, a cell-wall-associated region, a number of repeat regions and a variable length Nterminal non-helical region (Krebs et al. 1996) (Fig. 1) . The two cleavable domains are also present-the signal sequence and a CWS. From a comparison of 4 Mrp sequences from M2, M4, M49 and M76 isolates, it was found that the variability between proteins in this family is lower than compared with M proteins. Indeed, the signal peptide, which also contains the YSLRKX 3 GX 2 S motif, contains 90% amino acid identity over 41 residues (Podbielski, Weber-Heynemann and Cleary 1994) (Fig. 1) . Amino acid identity of the signal peptide in M proteins M1, M6, M12 and M24 was between 73% and 90%, and comparison of the Mrp76 signal peptide sequence with these sequences revealed 63% to 80% identity (Heath and Cleary 1989) .
Analysis of Mrp sequences suggests a predicted structure of the N-terminal region of a 40-50 amino acid random coil, like that seen in M proteins (Podbielski, Weber-Heynemann and Cleary 1994) . When translated sequences from 33 different mrp genes were compared, the amino acid identity within the Nterminal 80-90 amino acids was only 19.7% (Dale et al. 2015) (Fig. 1) . A study comparing 70-bp N-terminal sequences of mrp genes from 37 different strains defined six distinct mrp gene types, with over 50% sequence variation between gene types and over 95% sequence identity within a gene type (Krebs et al. 1996) . The six distinct mrp gene types were for the most part in agreement with three structurally related Mrp families described by Dale et al. , based on the translated sequence of the N-terminal 80-90 amino acids of 33 mrp genes, though only 18 strains were analysed in both studies. Amino acid sequence identity within each family ranged from 72% to 100% and between families from 14% to 40% (Krebs et al. 1996; Dale et al. 2015) . Analysis of N-terminal sequences of both mrp and emm genes from individual isolates found different mrp alleles in isolates of the same emm type, suggesting interstrain recombination (Krebs et al. 1996) . The similar pattern of variability suggests that like M protein, Mrp may undergo antigenic diversification to avoid immune detection (Heath and Cleary 1989) .
Following the N-terminal region, Mrp contains a central core of around 72 to 85 aa, rich in glutamate and glutamine (EQ-rich) that has 93% amino acid identity within published Mrp sequences from M2, M49, M76 and M4 (Podbielski, WeberHeynemann and Cleary 1994) (Fig. 1) . In the next region, which contains heptad repeat sequences, Mrp amino acid sequences have little sequence similarity to M and Enn proteins and have a different sequence structure lacking the variable spacerregion observed between C-repeats, and the 3-8 amino acid interruptions in the helical portions of M and Enn proteins, which are known to produce regions of random coil or turns (Podbielski, Weber-Heynemann and Cleary 1994) . The repeats in Mrp proteins are termed A-repeats and are made up of three 35 amino acid repeats in Mrp4 with a fourth 30 amino acid repeat in Mrp76 (Heath, Boyle and Cleary 1990; O'Toole et al. 1992) (Fig. 1) .
Like M proteins, Mrp amino acid sequences contain LPXTG motifs in their C-terminal (3 end of the gene), and thus are believed to be attached to the cell wall by sortase enzymes in a similar manner to M proteins. The motif is found in a PGTSrich domain, ∼52 amino acids in length that has 94% amino acid identity within four published mrp sequences (Podbielski, Weber-Heynemann and Cleary 1994) . Following the PGTS region, a 17 amino acid consensus sequence common to all three families of proteins is found on the C-terminal side of the cell-wallassociated region (Podbielski, Weber-Heynemann and Cleary 1994) (Fig. 1) . The cell-wall-associated domain is ∼50% shorter in Mrp compared to M proteins, and has 93% amino acid identity in the four aforementioned mrp sequences (Podbielski, WeberHeynemann and Cleary 1994) . Pack, Podbielski and Boyle (1996) Enn5 M5 35 aa consensus sequence, EQ-rich region Pack, Podbielski and Boyle (1996) Enn95 M95 35 aa consensus sequence, EQ-rich region Podbielski et al. ( , 1996 Fig. 4 ). The localisation of the fibrinogen-binding domain within Mrp was investigated in western blot assays using truncated recombinant Mrp peptides (based on the Mrp4 sequence) and probing with biotinylated fibrinogen. Results of these assays revealed two separate fibrinogen-binding domains (FBD1 and FBD2) in the N-terminal region of Mrp4, one of which (FBD2) mapped to a highly conserved region (Courtney, Hasty and Dale 2006) . Li and Courtney (2011) further refined the localisation of FBD1 to the first 55 N-terminal amino acids of the mature Mrp, with essential amino acids encompassing residues 44-55; likewise, FBD2 was mapped to amino acid residues 81-138, with residues 82-97 deemed crucial for fibrinogen binding (Li and Courtney 2011) . These distinct fibrinogen-binding domains may explain the conservation of function despite over 50% diversity in sequence found in the N-terminal region of mrp genes from 32 serotypes (Krebs et al. 1996) . The fibrinogen-binding motifs found in Mrp (FBD1 and FBD2) differ from those found in the various fibrinogen-binding M proteins (Li and Courtney 2011) , suggesting these domains may have evolved independently. Analysis of all available Mrp sequences revealed the conservation of the hypothetical fibrinogen-binding domain FBD2 (Li and Courtney 2011) . GAS express a number of different proteins that have been shown to bind to immunoglobulin (Ig) molecules in a nonimmune fashion through interactions with the Ig Fc domains. Table 1 for details).
Different Ig-binding proteins exhibit varied specificities and affinities to Ig classes, subclasses and species of origin. Mrp, like the M protein, have a class IIa reactivity profile in that they preferentially bind to human IgG of subclasses IgG 1 , IgG 2 and IgG 4 in the interface of the CH2 and CH3 domains of the Fc region (Heath, Boyle and Cleary 1990; Boyle et al. 1994) . The preferential binding of human IgG over IgG from many other animals led investigators to suggest a role for Mrp in determination of host specificity (Courtney and Li 2013) . As Mrp and M proteins are coexpressed in many GAS strains, there appears to be a level of functional redundancy, which is often observed in critical virulence systems. All investigations into the Ig-binding properties of Mrp have revealed similar subclass binding preferences, with varying levels of affinity, suggesting conservation in function and binding sequence (Stenberg, O'Toole and Lindahl 1992) . Indeed, the binding of IgG to Mrp has been mapped to the A-repeat region, which is highly conserved across Mrp proteins (Heath, Boyle and Cleary 1990; Courtney and Li 2013) . Despite sharing numerous common ligands with the M protein, C4BP binding was not detected in Mrps isolated from strains M4, M60 and M22 (Thern et al. 1995) .
Enn protein
Although there is common regulation of emm and enn genes by Mga, in a number of strains the level of expression of enn genes has been shown to be far lower than that of the emm genes. For example, the signal intensity from oligonucleotide probes in northern blots of total cellular RNA following culture in ToddHewitt broth was quantified in an M2 isolate and it was determined that the emm transcript level exceeded that of the enn gene by at least 32-fold (Bessen and Fischetti 1992) . The same result was observed after passage in human blood, where the transcript for the emm gene from an M49 isolate (CS101) was found to exceed that of the enn gene by 16-fold to 32-fold. As no clear differences were observed in promoter sequences, it was postulated that the low level of enn RNA could be due to lower stability of the molecule or the uncharacterised existence of a negative regulator (Podbielski, Flosdorff and Weber-Heynemann 1995) . When the sequence of the enn gene from an M4 reference strain (AP4) was determined, it was found to lack a typical start codon and the authors found no gene product when attempting to express this gene in an E. coli expression system. The authors suggested that the role of the unexpressed gene may be as a genetic reservoir for emm diversity though they also recognised the possibility that a mutation in a codon predicted to be optimal for translational initiation may have resulted in an inactive start codon (Jeppson, Frithz and Hedén 1992) . Upon comparison with more recently published enn sequences, it is evident that this mutation has substituted the typical start-codon encoding a methionine with one encoding a threonine residue Podbielski, Weber-Heynemann and Cleary 1994) .
The enn gene sequenced from an M2 isolate was compared with the emm gene from the same strain, with predicted 331 and 366 amino acid ORFs, respectively, and found to contain only 53% amino acid identity, with significant variability in the N-terminal third of the proteins. The protein sequence of the M2 Enn was found to bear 82% identity with the Enn protein derived from an M49 isolate (Bessen and Fischetti 1992) . As with Mrp, Enn proteins are believed to have similar structures to M proteins (Heath and Cleary 1989; Bessen and Fischetti 1992) as all share several structural domains including the PGTS region, the cellwall-associated region, a repeat region (A-repeats in Mrp and Crepeats in Enn) and a variable length N-terminal region (Krebs et al. 1996) .
The signal peptide of Enn proteins is a 41 amino acid sequence with 95% identity across Enn49, Enn2 and Enn8 (Podbielski, Weber-Heynemann and Cleary 1994) . From comparison of the 5 region of 31 different enn genes, the number of substitutions per site in the N-terminus has been found to be around 10-fold lower than that of emm genes. This analysis included 12 amino acids of the signal peptide and 48 amino acids of the predicted mature protein (Whatmore et al. 1995) . Suggestions for the drivers of this lower variability include less exposure to the immune system due to the lower level of expression (Podbielski, Weber-Heynemann and Cleary 1994), the emergence of enn genes more recently and thus less time for the accumulation of mutations, or a higher rate of horizontal transfer and recombination in the enn gene family leading to homogenisation of sequences (Whatmore et al. 1995) . The length of the N-terminal in published enn sequences is thought to be 67-74 amino acids long (Haanes and Cleary 1989; Bessen and Fischetti 1992; Bessen and Hollingshead 1994; Pack, Podbielski and Boyle 1996) (Fig. 1) . In the same study of 31 5 enn sequences, evidence of horizontal transfer of genes within the emm and emm-like family was provided by the existence of highly similar enn sequences in strains with divergent emm genes, as well as the existence of dissimilar enn sequences in strains with similar emm genes. Intragenic recombination was also predicted to have occurred between enn genes from M44 and M2 strains, creating a hybrid enn gene that was found in an M22 isolate (Whatmore et al. 1995) . Another version of M-like gene mosaicism has been reported in enn genes from M5 and M95 isolates, in which there appears to be a recombination of the C-terminal portion of an enn gene with the N-terminal portion of an emm gene Whatmore and Kehoe 1994) . Genetic mosaicism is a feature of multiple surface-exposed GAS proteins (Whatmore and Kehoe 1994; Ramachandran et al. 2004; Towers et al. 2013) . It is thought to be a mechanism of evading host immune responses, and also contributes to functional diversity of proteins. The significance of M-like gene mosaicism in terms of GAS pathogenesis has not been investigated; however, it can be speculated that recombination between M-family genes ensures conservation of interactions with important host proteins, whilst also providing antigenic variation.
The EQ-rich central core region in M proteins and Mrp of E pattern background is replaced in enn sequences isolated from M2, M4 and M49 with an 18 amino acid motif (Bessen and Fischetti 1992; Podbielski, Weber-Heynemann and Cleary 1994) (Fig. 1) . However, Enn proteins isolated from M18 and M95 backgrounds have a central core more homologous to that found in M and Mrp proteins Pack, Podbielski and Boyle 1996) . Following the core region, the C-repeat regions of the three sequences analysed by Podbielski, Weber-Heynemann and Cleary 1994) (Enn49, Enn2 and Enn8) comprised 23 amino acid repeats in triplicate, with two intervening regions of spacer sequence of variable length, thought to produce regions of random coil. As found in Mrp, a 17 amino acid consensus sequence follows the PGTS region (Podbielski, Weber-Heynemann and Cleary 1994) .
The cell-wall-associated domains from Enn49, Enn2 and Enn8 are twice the length of that of Mrp and have 98% identity (Podbielski, Weber-Heynemann and Cleary 1994) . The PGTS-rich domain is 44 amino acids in these Enn sequences and has 100% amino acid identity (Fig. 1) . The C-terminal regions of Enn proteins share 100% amino acid identity with that of M proteins from OF + strains, but only 76% with M proteins of OF − strains (Bessen and Fischetti 1992) . As this sequence is downstream of the LPTXG motif, it would theoretically be cleaved in the mature protein.
Enn-binding partners
Enn protein-binding partners have been investigated in vitro and in silico. The non-immune binding of IgA appears to be a common attribute of Enn proteins from diverse backgrounds (Bessen and Fischetti 1992; Johnsson et al. 1994; Podbielski, Weber-Heynemann and Cleary 1994) (Fig. 4) . In order to map the IgA-binding domain from the Enn protein isolated from an M2 strain, the deduced sequence was compared with that of the M4 protein, which was also known to bind IgA. The binding was mapped to the N-terminal third of both proteins, despite this region containing the most diversity. IgA binding was mapped to a short consensus sequence, with identity at 8 out of 10 residues, indicating that a common IgA-binding motif is shared between the proteins from different families (Bessen 1994 ). Fig. 4 ). These genes are suggested to have arisen by intergenic recombination between the C-terminal portion of the enn gene and the N-terminal portion of an emm gene, evidence for which is the presence of an EQ-rich region typical of M proteins in the Enn proteins (Whatmore and Kehoe 1994; Pack, Podbielski and Boyle 1996) . The binding of IgG 3 has been theoretically mapped to a 35 amino acid sequence in this EQ-rich region, downstream of the variable N-terminal region, as is the case in a number of M and M-like proteins (Pack, Podbielski and Boyle 1996) .
An Enn protein isolated from an M18 strain of GAS, which does not encode an mrp gene, has been shown to bind C4BP (Pérez-Caballero et al. 2004) . Binding of C4BP requires experimental validation, as an M protein C4BP-binding motif is yet to be confirmed and the interaction is believed to require the structural conformation of the mature proteins (Persson et al. 2006) . However, a recent study has described the possibility of conserved sequence patterns within the hypervariable sequence of M proteins, which combined with a relatively flexible binding site in C4BP allows for the conservation of this interaction across diverse M proteins (Buffalo et al. 2016) . Currently identified binding partners for both Enn and Mrp proteins are compiled in Table 1 and Fig. 4 ; however, given the similarities between these and M protein it is likely that more binding partners exist that are as yet unidentified.
CONTRIBUTION TO VIRULENCE
Due to the marked similarities in structure and function between M and M-like proteins, it was long thought that they may play a similar role in immune evasion during infection (Fig. 4 ). An important function of the M protein is to inhibit the activation of the complement system, an innate immune mechanism involving several serum proteins. Different M proteins have been shown to inhibit complement by differing mechanisms, including the binding of fibrinogen, plasminogen and the negative regulator of complement C4BP (Smeesters, McMillan and Sriprakash 2010; Ly et al. 2014) . Mrp was shown to be an antiphagocytic protein by Podbielski et al. (1996) , who investigated the association of GAS with granulocytes using isogenic emmlike gene mutants of strains with serotype M2, M4, M49 and M95. Inactivation of mrp significantly reduced the ability of GAS to survive in human blood in three out of four strain backgrounds, and in one of these inactivation of mrp had as much effect as inactivation of emm. In this study, strains of both emm − and mrp − mutants were associated with more granulocytes and phagocytosed more rapidly in non-immune blood . Another study in which an M22 clinical isolate was used found that inactivation of emm or mrp alone did not reduce the ability of bacteria to survive in blood, indicating that the Mrp protein was able to support the antiphagocytic properties of the strain in the absence of M protein (Thern, Wastfelt and Lindahl 1998) . The mechanisms of this antiphagocytic activity were shown, in an M4 strain by Courtney, Hasty and Dale (2006) to be at least in part mediated by the binding of fibrinogen to Mrp. Growth of an M4 GAS isolate in blood was only possible in the presence of fibrinogen; in the absence of fibrinogen, there was a 2-fold increase in the deposition of C3b on the bacterial surface. Inactivation of the mrp gene dramatically reduced the ability of the bacteria to bind fibrinogen in immunoassays resulting in a 2-fold increase of C3b bound to the surface of this mrp − mutant strain in the presence of fibrinogen. The deposition of C3b was not observed in the presence of Mg-EGTA, which suggests that the inhibitory effects of fibrinogen were mediated by blocking activation by the classical complement pathway. In this M4 isolate, the contribution of Mrp to phagocytosis resistance in blood appeared to be greater than that of the M protein, though this is not thought to be the case for the majority of strains (Courtney, Hasty and Dale 2006) . It has been shown for M4, M22, M28 and M60 and in a separate study for M2, M49 and M95, which when present, Mrp is the major fibrinogen-binding protein on the surface of GAS, a role filled by the M protein in the absence of Mrp (Stenberg, O'Toole and Lindahl 1992; Podbielski et al. 1996) . Interestingly, the addition of peptides containing the fibrinogenbinding sequences of Mrp to human blood was shown to inhibit the binding of fibrinogen to GAS and thus promote phagocytosis (Li and Courtney 2011) . Another confirmed function of Mrp proteins, the ability to bind IgG in a non-immune manner, has also been shown to contribute to phagocytosis resistance. A mutant was constructed in an M4 background with an in-frame deletion of the IgG-binding domain of Mrp that significantly reduced the ability of the bacteria to grow in blood, despite retaining fibrinogen-binding capacity (Courtney and Li 2013 . It has been suggested that the non-immune binding of Ig molecules may lead to evasion of the host immune system, for example, by coating otherwise antigenic epitopes of surface proteins, resulting in bacteria appearing as non-foreign (Podbielski, Weber-Heynemann and Cleary 1994) . The binding of both fibrinogen and IgG suggests that Mrp could act as another antiphagocytic virulence factor for GAS.
M-like proteins have been shown, with notable differences among strains, to be involved in the maintenance of lipotechoic acid (LTA) on bacterial surfaces, a known function of M proteins, which may aid in the formation of biofilms and in colonisation of the oropharynx (Beachey and Simpson 1982; Hasty et al. 1992) . Courtney et al. (2009) found that inactivation of the mrp gene in an M2 strain had no effect on the ability of the bacteria to form biofilms, whereas loss of the mrp gene in an M4 strain reduced biofilm formation by 96%. Inactivation of the emm and enn genes in this M4 strain had no effect on biofilm formation; however, the enn mutant was found to complex less LTA than the wild-type strain. The authors also found that mrp inactivation in an M49 strain reduced biofilm formation but not hydrophobicity or the protein-bound LTA compared to the wild type. Together, these results suggest that the Enn protein may contribute to the interaction of LTA with the bacterial surface, and that Mrp proteins may be involved in biofilm formation, though potentially not through interactions with LTA.
IMMUNOGENICITY
More recently, the protective immunogenicity of Mrp has been demonstrated. Rabbit antisera raised against an Mrp N-terminal peptide derived from the sequence of an M65 clinical isolate was shown to be opsonic in human blood. Rabbit antisera against Mrp resulted in 46% killing in bactericidal assays, which was comparable to antisera against the M protein from the same strain in parallel assays (65% killing). Fluorescence microscopy revealed the interaction between the rabbit anti-Mrp antibodies and complement proteins indicating the observed killing was due to opsonic antibodies (Niedermeyer et al. 2014) . Further evidence of the immunogenicity of Mrp includes passive immunisation with rabbit antisera raised against an N-terminal Mrp peptide from an M4 strain, which led to increased survival of mice subsequently challenged with live GAS. The same study found evidence of natural anti-Mrp antibodies in human subjects, which were found at higher levels in the older subjects. These human antibodies were purified and found to promote killing of GAS in bactericidal assays (Dale et al. 2015) . A trivalent Mrp vaccine has recently been tested in rabbits and was shown to induce opsonic antibodies against GAS strains that express Mrp proteins. The antisera were combined with antisera following vaccination with the 30-valent M protein vaccine and were shown to be more opsonic in combination than either sera alone in a number of GAS strains, including against a strain from which the M protein is included in the 30-valent vaccine (Dale et al. 2011 (Dale et al. , 2013 Courtney et al. 2017) . Based on whole genome sequencing of GAS recovered from invasive disease in the USA during 2015, inclusion of the trivalent Mrp vaccine in conjunction with the 30-valent M protein vaccine could increase coverage from 88.7% to 98.3% of invasive isolates (Chochua et al. 2017) .
CONCLUSIONS
Despite substantial similarities between M, Mrp and Enn proteins, the M-like proteins remain relatively unstudied. The information available highlights considerable sequence similarities, particularly in the C-terminal regions of the proteins. It is perhaps unsurprising then that Mrp and Enn proteins exhibit ligand-binding previously characterised for M proteins; however, the genetic diversity of mrp and enn appears to be far lower than that of emm. The majority of early studies on the M protein focussed on strains that were lacking mrp and enn genes, but it has since been shown that when present, these proteins supersede the M protein in requirement for binding of certain host proteins. The Mrp protein is a major fibrinogen-binding protein and has also an IgG-binding domain in the relatively conserved A-repeat region. The identified fibrinogen-binding motif in the N-terminal of Mrp proteins differs to the fibrinogen-binding motif in M proteins. In contrast, Enn proteins and M proteins share a common IgA-binding consensus sequence, despite its location in the variable N-terminal region of both proteins. Based on the observed interactions with host proteins, an important role for M-like proteins is implicated during infection. Indeed, Mrp has been shown to be antiphagocytic and immunogenic, and evidence suggests the potential of Mrp to elicit protective immune responses. In conjunction with the restricted variability of M-like proteins compared to M proteins, the role of Mrp and Enn proteins as potential vaccine candidates requires further investigation. Finally, better understanding the added value for GAS in maintaining this trio of similar but different surface proteins would help in characterising the pathogenesis of a bacterium that contributes to a significant global burden of disease.
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